Snail, Inc. 8-K

What Happened
Snail, Inc. (SNAL) filed an 8-K reporting that on December 30, 2025 it received written notice from the Nasdaq Listing Qualifications Department that its common stock failed to maintain the $1.00 minimum closing bid required by Nasdaq Listing Rule 5550(a)(2). Nasdaq found the deficiency occurred for thirty (30) consecutive business days from November 11, 2025 through December 29, 2025. The notice does not immediately affect listing or trading; SNAL shares will continue to trade on the Nasdaq Capital Market under the symbol "SNAL."

Key Details

• Notice date: December 30, 2025; deficiency period: November 11–December 29, 2025 (30 consecutive business days).
• Compliance window: 180 calendar days under Nasdaq Rule 5810(c)(3)(A), expiring June 29, 2026.
• To regain compliance: a closing bid price of $1.00 or more for at least ten (10) consecutive business days during the compliance period (Nasdaq may require more days).
• If not cured, the company may request an additional 180-day extension by meeting Nasdaq’s market value and other initial listing standards (except the $1.00 bid rule) and notifying Nasdaq of intent to cure—often via a reverse stock split; Nasdaq may delist if the company is ineligible or cannot cure.

Why It Matters
This notice signals a risk that SNAL could face delisting from Nasdaq if it does not restore its stock price above $1.00 within the stated periods. Delisting can reduce liquidity and investor visibility. The company said it will monitor the situation and consider options, including a reverse stock split, but warned there is no assurance it will regain compliance. Investors should watch SNAL’s closing bid, any company announcements about remediation steps, and Nasdaq communications through June 29, 2026 (and possibly beyond).